Related references
Note: Only part of the references are listed.CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin
Sara A. Wickstroem et al.
EMBO JOURNAL (2010)
Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6
Yuliya Zilberman et al.
JOURNAL OF CELL SCIENCE (2009)
HDAC6 Regulates Androgen Receptor Hypersensitivity and Nuclear Localization via Modulating Hsp90 Acetylation in Castration-Resistant Prostate Cancer
Junkui Ai et al.
MOLECULAR ENDOCRINOLOGY (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
Jennifer S. Carew et al.
CANCER LETTERS (2008)
The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis
Yi-Shan Lee et al.
CANCER RESEARCH (2008)
Role of the aggresorne pathway in cancer: Targeting histone deacetylase 6-dependent protein degradation
Agustin Rodriguez-Gonzalez et al.
CANCER RESEARCH (2008)
Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor
Martina Bazzaro et al.
CLINICAL CANCER RESEARCH (2008)
HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions
Agustin Valenzuela-Fernandez et al.
TRENDS IN CELL BIOLOGY (2008)
The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response
SoHee Kwon et al.
GENES & DEVELOPMENT (2007)
Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis
Chengkai Dai et al.
CELL (2007)
HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination
C. Boyault et al.
ONCOGENE (2007)
HDAC6 modulates cell motility by altering the acetylation level of cortactin
Xiaohong Zhang et al.
MOLECULAR CELL (2007)
NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells
Claudia P. Miller et al.
BLOOD (2007)
HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions
Andy Dong-Anh Tran et al.
JOURNAL OF CELL SCIENCE (2007)
HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates
Cyril Boyault et al.
GENES & DEVELOPMENT (2007)
Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity
J. Roman Cabrero et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Characterization of the two catalytic domains in histone deacetylase 6
H Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Two catalytic domains are required for protein deacetylation
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
HDAC6 and microtubules are required for autophagic degradation of aggregated Huntingtin
A Iwata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone
PJM Murphy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors
C Bradbury et al.
LEUKEMIA (2005)
Cortactin promotes cell motility by enhancing lamellipodial persistence
NS Bryce et al.
CURRENT BIOLOGY (2005)
Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer
S Saji et al.
ONCOGENE (2005)
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma
T Hideshima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase
AI Marcus et al.
CANCER RESEARCH (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
HDAC6 expression is correlated with better survival in breast cancer
ZH Zhang et al.
CLINICAL CANCER RESEARCH (2004)
The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress
Y Kawaguchi et al.
CELL (2003)
Histone deacetylases
PA Marks et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
Class II histone deacetylases: versatile regulators
E Verdin et al.
TRENDS IN GENETICS (2003)
Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays
SJ Haggarty et al.
CHEMISTRY & BIOLOGY (2003)
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation
SJ Haggarty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo
Y Zhang et al.
EMBO JOURNAL (2003)
In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation
A Matsuyama et al.
EMBO JOURNAL (2002)
Development of cDNA microarray for expression profiling of estrogen-responsive genes
A Inoue et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2002)
Regulation of substrate adhesion dynamics during cell motility
I Kaverina et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
Hassles with taking out the garbage: Aggravating aggresomes
R Garcia-Mata et al.
TRAFFIC (2002)
HDAC6 is a microtubule-associated deacetylase
C Hubbert et al.
NATURE (2002)
Identification of components of the murine histone deacetylase 6 complex: Link between acetylation and ubiquitination signaling pathways
D Seigneurin-Berny et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Histone deacetylases and cancer: Causes and therapies
PA Marks et al.
NATURE REVIEWS CANCER (2001)
From the cradle to the grave:: molecular chaperones that may choose between folding and degradation
J Höhfeld et al.
EMBO REPORTS (2001)
Share Paper
